Sonic GP LLC’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$3.12M Hold
403,079
6.87% 5
2024
Q3
$4.23M Sell
403,079
-50,000
-11% -$610K 9.66% 4
2024
Q2
$5.3M Sell
453,079
-90,000
-17% -$1.4M 10.94% 3
2024
Q1
$11.4M Buy
543,079
+100,000
+23% +$1.78M 15.1% 2
2023
Q4
$7.95M Sell
443,079
-75,000
-14% -$1.32M 9.14% 3
2023
Q3
$8.53M Sell
518,079
-225,000
-30% -$4.08M 8.28% 3
2023
Q2
$14.9M Buy
743,079
+550,000
+285% +$10.6M 9.91% 3
2023
Q1
$3.65M Hold
193,079
2.79% 15
2022
Q4
$4.38M Buy
+193,079
New +$4.36M 3.29% 14

Other funds holding RGNX

Sonic GP LLC's RGNX Position: Q4 2024 in Review

Sonic GP LLC held its Regenxbio (RGNX) position steady in Q4 2024 at 403,079 shares worth $3.12M. The position accounts for 6.87% of the portfolio, ranked #5.

Sonic GP LLC first reported a position in RGNX in Q4 2022 and has held it in 9 quarters since. The position peaked at $14.9M in Q2 2023. 177 funds tracked by Wall St. Rank hold RGNX as of Q4 2024.

  • Sonic GP LLC held 403,079 shares of Regenxbio worth $3.12M as of Q4 2024.
  • Sonic GP LLC left its Regenxbio share count unchanged in Q4 2024.
  • Regenxbio made up 6.87% of Sonic GP LLC's portfolio in Q4 2024, its #5 holding.
  • Sonic GP LLC first reported a position in Regenxbio in Q4 2022 and has held it in 9 quarters since.
  • Sonic GP LLC's Regenxbio position peaked at $14.9M in Q2 2023.
  • 177 funds tracked by Wall St. Rank held Regenxbio as of Q4 2024.

Based on Sonic GP LLC's 13F filing for Q4 2024, filed 14 Feb 2025.